Are you over 18 and want to see adult content?
More Annotations
A complete backup of https://drivenow.com.au
Are you over 18 and want to see adult content?
A complete backup of https://synved.com
Are you over 18 and want to see adult content?
A complete backup of https://atia.org
Are you over 18 and want to see adult content?
A complete backup of https://finecheese.co.uk
Are you over 18 and want to see adult content?
A complete backup of https://gesundheit.de
Are you over 18 and want to see adult content?
A complete backup of https://mysteryspot.com
Are you over 18 and want to see adult content?
A complete backup of https://mercadopago.com
Are you over 18 and want to see adult content?
A complete backup of https://bedford.gov.uk
Are you over 18 and want to see adult content?
A complete backup of https://subaru.ch
Are you over 18 and want to see adult content?
A complete backup of https://empea.org
Are you over 18 and want to see adult content?
A complete backup of https://garrettplanningnetwork.com
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of filmstreaming-de.life
Are you over 18 and want to see adult content?
A complete backup of aim-sportline.com
Are you over 18 and want to see adult content?
A complete backup of tobaccotactics.org
Are you over 18 and want to see adult content?
A complete backup of thehanovertheatre.org
Are you over 18 and want to see adult content?
A complete backup of paterson-education.org
Are you over 18 and want to see adult content?
A complete backup of spherestandards.org
Are you over 18 and want to see adult content?
Text
the UK.
HYBRID CLOSED LOOP TECHNOLOGY FOR TYPE 1 DIABETES COULD BE Hybrid closed loop technology for type 1 diabetes could be available on the NHS by 2022. Posted on 16 April 2021. The National Institute for Health and Care Excellence (NICE) has confirmed that it will be appraising hybrid closed loop technology for type 1 diabetes, meaning that it could be available on the NHS in England as early as nextyear.
SCHOOLS E-LEARNING MODULE Schools e-learning module. Take our free e-learning module for schools to learn more about supporting pupils with type 1 diabetes in educational settings. The incidence of type 1 diabetes is increasing by four per cent each year. Current legislation states that it is the duty of staff who work with children or young people living type 1 THE GREAT SUNFLOWER CHALLENGE 2021 The Great Sunflower Challenge 2021. 01 Mar 2021 - 19 Jun 2021. £5.00. Register now. Let’s get growing for the 2021 Sunflower Challenge. The challenge is now in its eighth year and will raise funds for JDRF at the same time. Inspired by the success of their own sunflower growing efforts, Sarah Langton and Peter Kilby – whose son Oliverhas
TEPLIZUMAB IMMUNOTHERAPY CAN DELAY TYPE 1 DIABETES FOR Posted on 15 March 2021. JDRF has invested more than £115 million in immune therapy research to date. Teplizumab, the ground-breaking immunotherapy underpinned by JDRF research, can delay type 1 diabetes by an average of nearly three years. According to a newly published paper, half of people treated with teplizumab still have not developed FINANCIAL SUPPORT AT UNIVERSITY FOR STUDENTS WITH TYPE 1 JDRF, the type 1 diabetes charity. We fund research to cure, treat and prevent type 1. We work with government, academia and industry to accelerate research in the UK and within healthcare policy to ensure that the outcomes of research are delivered to people with type 1 inthe UK.
KIDNEY DISEASE IN TYPE 1 DIABETES (NEPHROPATHY) Kidney disease (nephropathy) When blood glucose is high, it can damage the blood vessels in your kidneys, leading to kidney disease. In its early stages, kidney disease doesn’t cause symptoms, but over time it can cause kidney failure. This means they stop working and dialysis is needed to clean the blood as the kidneys normally would. INSULIN PUMPS FOR TREATING TYPE 1 DIABETES Insulin pumps are an increasingly common treatment for type 1 diabetes. They can improve glucose control in people with type 1 diabetes but do not suit everyone. is a little smaller than a deck of cards – some are much smaller. delivers short acting insulin every few minutes in tiny amounts, 24 hours a day. the insulin flows througha cannula
PUMPS AND INFUSION SETS AVAILABLE IN THE UK JDRF, the type 1 diabetes charity. We fund research to cure, treat and prevent type 1. We work with government, academia and industry to accelerate research in the UK and within healthcare policy to ensure that the outcomes of research are delivered to people with type 1 inthe UK.
TYPE 1 LIVING WELL WITH TYPE 1 SPECIAL *Results from the real world data obtained since the global launch of Intellin® indicates that it may promote a reduction in blood pressure (Users of Intellin showed a 3.47% reduction in systolic BP and 6.58% in diastolic in a 12 month period). JDRF UK - TYPE 1 DIABETES RESEARCH JDRF, the type 1 diabetes charity. We fund research to cure, treat and prevent type 1. We work with government, academia and industry to accelerate research in the UK and within healthcare policy to ensure that the outcomes of research are delivered to people with type 1 inthe UK.
HYBRID CLOSED LOOP TECHNOLOGY FOR TYPE 1 DIABETES COULD BE Hybrid closed loop technology for type 1 diabetes could be available on the NHS by 2022. Posted on 16 April 2021. The National Institute for Health and Care Excellence (NICE) has confirmed that it will be appraising hybrid closed loop technology for type 1 diabetes, meaning that it could be available on the NHS in England as early as nextyear.
SCHOOLS E-LEARNING MODULE Schools e-learning module. Take our free e-learning module for schools to learn more about supporting pupils with type 1 diabetes in educational settings. The incidence of type 1 diabetes is increasing by four per cent each year. Current legislation states that it is the duty of staff who work with children or young people living type 1 THE GREAT SUNFLOWER CHALLENGE 2021 The Great Sunflower Challenge 2021. 01 Mar 2021 - 19 Jun 2021. £5.00. Register now. Let’s get growing for the 2021 Sunflower Challenge. The challenge is now in its eighth year and will raise funds for JDRF at the same time. Inspired by the success of their own sunflower growing efforts, Sarah Langton and Peter Kilby – whose son Oliverhas
CONNECT IMMUNE RESEARCH JDRF, the type 1 diabetes charity. We fund research to cure, treat and prevent type 1. We work with government, academia and industry to accelerate research in the UK and within healthcare policy to ensure that the outcomes of research are delivered to people with type 1 inthe UK.
CONNECT IMMUNE RESEARCH JDRF, the type 1 diabetes charity. We fund research to cure, treat and prevent type 1. We work with government, academia and industry to accelerate research in the UK and within healthcare policy to ensure that the outcomes of research are delivered to people with type 1 inthe UK.
KIDNEY DISEASE IN TYPE 1 DIABETES (NEPHROPATHY) Kidney disease (nephropathy) When blood glucose is high, it can damage the blood vessels in your kidneys, leading to kidney disease. In its early stages, kidney disease doesn’t cause symptoms, but over time it can cause kidney failure. This means they stop working and dialysis is needed to clean the blood as the kidneys normally would.PATHWAY TO CHOICE
Pathway to Choice is a partnership programme led by JDRF and supported by industry partners Abbott Diabetes Care, Dexcom, Insulet International Ltd and Roche Diabetes Care Ltd. The aim of the programme is to build awareness of and access to type 1 technology choices for people with type 1 diabetes. It does this through buildinginsight to
RESEARCH FIRST COULD HELP FOUR MILLION WITH AUTOIMMUNE Professor Yanick. Connect Immune Research is a collaboration between JDRF, MS Society and Versus Arthritis with support from the British Society for Immunology. The group estimates four million people in the UK are living with an autoimmune condition – which is more than six per cent of the population. This includes 400,000 people with type 1 INSULIN PUMPS FOR TREATING TYPE 1 DIABETES Insulin pumps are an increasingly common treatment for type 1 diabetes. They can improve glucose control in people with type 1 diabetes but do not suit everyone. is a little smaller than a deck of cards – some are much smaller. delivers short acting insulin every few minutes in tiny amounts, 24 hours a day. the insulin flows througha cannula
UPDATE ON FLASH GLUCOSE MONITORING ACCESS: A POSTCODE Thousands of UK adults and children with type 1 diabetes are still being denied access to flash glucose monitoring. Currently, only Northern Ireland, Wales, two in five areas in England and one in three in Scotland have made it available to people who meet local criteria. TEDDY PROJECT HIGHLIGHTS BENEFITS OF BEING DIAGNOSED JDRF, the type 1 diabetes charity. We fund research to cure, treat and prevent type 1. We work with government, academia and industry to accelerate research in the UK and within healthcare policy to ensure that the outcomes of research are delivered to people with type 1 inthe UK.
TYPE 1 LIVING WELL WITH TYPE 1 SPECIAL *Results from the real world data obtained since the global launch of Intellin® indicates that it may promote a reduction in blood pressure (Users of Intellin showed a 3.47% reduction in systolic BP and 6.58% in diastolic in a 12 month period). STUDY SUGGESTS NEW HBA1C 'SWEET SPOT' TO REDUCE RISKS OF Shedding new light on risks associated with having low HbA1c, these findings suggest that people with type 1 may be able to minimise the risks of developing complications by keeping at HbA1c levels between 6.5% and 6.9%. While the current benchmark of 6.5% or lower also helps people to avoid these risks, this study suggests that this HbA1c may MHRA'S ADVICE TO FREESTYLE LIBRE USERS EXPERIENCING SKIN Skin reactions to the sensor adhesive used in the FreeStyle Libre flash glucose monitor devices have been reported to the Medicine and Healthcare products Regulatory Agency (MHRA) which regulates all medicines and medical devices. Users who are experiencing the symptoms, which include redness, itching or blistering, are advised bythe MHRA not
JDRF UK - TYPE 1 DIABETES RESEARCH JDRF, the type 1 diabetes charity. We fund research to cure, treat and prevent type 1. We work with government, academia and industry to accelerate research in the UK and within healthcare policy to ensure that the outcomes of research are delivered to people with type 1 inthe UK.
SCHOOLS E-LEARNING MODULE Schools e-learning module. Take our free e-learning module for schools to learn more about supporting pupils with type 1 diabetes in educational settings. The incidence of type 1 diabetes is increasing by four per cent each year. Current legislation states that it is the duty of staff who work with children or young people living type 1 CONNECT IMMUNE RESEARCH JDRF, the type 1 diabetes charity. We fund research to cure, treat and prevent type 1. We work with government, academia and industry to accelerate research in the UK and within healthcare policy to ensure that the outcomes of research are delivered to people with type 1 inthe UK.
HYBRID CLOSED LOOP TECHNOLOGY FOR TYPE 1 DIABETES COULD BE Hybrid closed loop technology for type 1 diabetes could be available on the NHS by 2022. Posted on 16 April 2021. The National Institute for Health and Care Excellence (NICE) has confirmed that it will be appraising hybrid closed loop technology for type 1 diabetes, meaning that it could be available on the NHS in England as early as nextyear.
TEPLIZUMAB IMMUNOTHERAPY CAN DELAY TYPE 1 DIABETES FOR Posted on 15 March 2021. JDRF has invested more than £115 million in immune therapy research to date. Teplizumab, the ground-breaking immunotherapy underpinned by JDRF research, can delay type 1 diabetes by an average of nearly three years. According to a newly published paper, half of people treated with teplizumab still have not developed FINANCIAL SUPPORT AT UNIVERSITY FOR STUDENTS WITH TYPE 1 JDRF, the type 1 diabetes charity. We fund research to cure, treat and prevent type 1. We work with government, academia and industry to accelerate research in the UK and within healthcare policy to ensure that the outcomes of research are delivered to people with type 1 inthe UK.
JDRF UK - TYPE 1 DIABETES RESEARCH JDRF, the type 1 diabetes charity. We fund research to cure, treat and prevent type 1. We work with government, academia and industry to accelerate research in the UK and within healthcare policy to ensure that the outcomes of research are delivered to people with type 1 inthe UK.
SCHOOLS E-LEARNING MODULE Schools e-learning module. Take our free e-learning module for schools to learn more about supporting pupils with type 1 diabetes in educational settings. The incidence of type 1 diabetes is increasing by four per cent each year. Current legislation states that it is the duty of staff who work with children or young people living type 1 CONNECT IMMUNE RESEARCH JDRF, the type 1 diabetes charity. We fund research to cure, treat and prevent type 1. We work with government, academia and industry to accelerate research in the UK and within healthcare policy to ensure that the outcomes of research are delivered to people with type 1 inthe UK.
HYBRID CLOSED LOOP TECHNOLOGY FOR TYPE 1 DIABETES COULD BE Hybrid closed loop technology for type 1 diabetes could be available on the NHS by 2022. Posted on 16 April 2021. The National Institute for Health and Care Excellence (NICE) has confirmed that it will be appraising hybrid closed loop technology for type 1 diabetes, meaning that it could be available on the NHS in England as early as nextyear.
TEPLIZUMAB IMMUNOTHERAPY CAN DELAY TYPE 1 DIABETES FOR Posted on 15 March 2021. JDRF has invested more than £115 million in immune therapy research to date. Teplizumab, the ground-breaking immunotherapy underpinned by JDRF research, can delay type 1 diabetes by an average of nearly three years. According to a newly published paper, half of people treated with teplizumab still have not developed FINANCIAL SUPPORT AT UNIVERSITY FOR STUDENTS WITH TYPE 1 JDRF, the type 1 diabetes charity. We fund research to cure, treat and prevent type 1. We work with government, academia and industry to accelerate research in the UK and within healthcare policy to ensure that the outcomes of research are delivered to people with type 1 inthe UK.
TYPE 1 DIABETES AWARENESS CAMPAIGNS JDRF campaigns aim to raise awareness of type 1 diabetes, encourage a positive view of the condition, bring people together to show the world what people with type 1 can do - as well as raising money to fund research to cure, prevent and treat type 1. INFORMATION FOR EDUCATION AND HEALTHCARE PROFESSIONALS JDRF, the type 1 diabetes charity. We fund research to cure, treat and prevent type 1. We work with government, academia and industry to accelerate research in the UK and within healthcare policy to ensure that the outcomes of research are delivered to people with type 1 inthe UK.
HYBRID CLOSED LOOP TECHNOLOGY FOR TYPE 1 DIABETES COULD BE Hybrid closed loop technology for type 1 diabetes could be available on the NHS by 2022. Posted on 16 April 2021. The National Institute for Health and Care Excellence (NICE) has confirmed that it will be appraising hybrid closed loop technology for type 1 diabetes, meaning that it could be available on the NHS in England as early as nextyear.
SIGNS AND SYMPTOMS OF TYPE 1 DIABETES The main signs and symptoms of type 1 diabetes include: Going to the toilet more. Your body will try to get rid of excess glucose through urination. Being extremely thirsty. If you’re going to the toilet more, you’ll be very thirsty. Tiredness. PUMPS AND INFUSION SETS AVAILABLE IN THE UK JDRF, the type 1 diabetes charity. We fund research to cure, treat and prevent type 1. We work with government, academia and industry to accelerate research in the UK and within healthcare policy to ensure that the outcomes of research are delivered to people with type 1 inthe UK.
TYPE 1 DIABETES AND SICKNESS JDRF, the type 1 diabetes charity. We fund research to cure, treat and prevent type 1. We work with government, academia and industry to accelerate research in the UK and within healthcare policy to ensure that the outcomes of research are delivered to people with type 1 inthe UK.
TYPE 1 DIABETES, EXERCISE AND SPORT Exercise and type 1 diabetes. Exercise is an important part of your general health, but it also helps you to maintain good type 1 diabetes management. Adjusting food and insulin around exercise can be tricky, as different types of exercise can have a different effect on you. You’ll need to find the right plan that works for you before, during SURVEY EXPLORING YOUNG ADULTS’ VIEWS ABOUT FACTORS Researchers at City University of London are inviting people aged 18-34 years living with diabetes to complete an online survey that explores a number of issues that may affect their attendance at diabetic eye screening and views on the screening process. RESEARCH FIRST COULD HELP FOUR MILLION WITH AUTOIMMUNE Professor Yanick. Connect Immune Research is a collaboration between JDRF, MS Society and Versus Arthritis with support from the British Society for Immunology. The group estimates four million people in the UK are living with an autoimmune condition – which is more than six per cent of the population. This includes 400,000 people with type 1 KIDNEY DISEASE IN TYPE 1 DIABETES (NEPHROPATHY) Kidney disease (nephropathy) When blood glucose is high, it can damage the blood vessels in your kidneys, leading to kidney disease. In its early stages, kidney disease doesn’t cause symptoms, but over time it can cause kidney failure. This means they stop working and dialysis is needed to clean the blood as the kidneys normally would.Skip to content
* Shop
* Blog
__ __
__
__
* Information & support * About type 1 diabetes * Causes of type 1 diabetes * Signs and symptoms of type 1 diabetes * What is the difference between type 1 and type 2 diabetes? * Type 1 diabetes facts and figures* Type 1 TV
* The honeymoon phase* Complications
* Other autoimmune conditions * Managing type 1 diabetes * Managing blood glucose levels * What should my blood glucose levels be? * How do I check my blood glucose levels?* What is an HbA1c?
* Managing a hypo
* Managing a hyper
* Carb counting
* Type 1 diabetes management skills * Treatments & technologies * Blood glucose meters * Continuous glucose monitors * Flash glucose sensing* Insulin
* Injecting insulin
* Insulin pump therapy* Islet transplants
* Biosimilars
* Open source decision tools * Closed-loop / artificial pancreas systems * Newly diagnosed with type 1 diabetes * Support for newly-diagnosed children * Support for newly-diagnosed adults * Information packs and leaflets * The type 1 diabetes community * Type 1 Diabetes Discovery Days* Useful links
* Sign up to our e-newsletter * Living with type 1 diabetes* Everyday life
* Health and wellness * Healthcare support * Type 1 Discovery magazine* Our research
* About our research* Cure research
* Treatment research * Prevention research * Meet our researchers * Connect Immune Research * Type 1 diabetes research and the EU * The Diabetes Ireland Research Alliance * Get involved in research * What is a clinical trial? * JDRF clinical trials * Clinical trial finder tool * What is it like to take part? * Understanding Science Toolkit * Current research projects * Cure research projects * Prevention research projects * Treatment research projects * Information for researchers * Current opportunities * How to apply for a research grant * Research resources * Research to reality * Type 1 Research Today Report * Type 1 Diabetes Research Roadmap* Get involved
* Fundraise
* Events
* Hold a virtual Type 1 Tea Party * Organise your own event * Fundraise at school * Fundraising materials* Give
* Donate or pay in money * Making a gift in your Will * Celebrate and donate* Donate in memory
* Payroll giving
* Gift Aid
* Free and easy ways to give * Products supporting us* Volunteer
* Volunteering opportunities * Why volunteer for JDRF?* Volunteering FAQs
* Speak out
* Research funding advocacy * Treatment advocacy * Help us to speak out * Reports and resources * Corporate, Trusts & Philanthropy * Corporate partnerships * Our corporate partners * Trusts and foundations* Philanthropy
* News & media
* Latest news
* Media centre
* Information for journalists * Our celebrity supporters* Campaigns
* The DiaDigits Calculator* T1D Looks Like Me
* Mark your #diaversary* Be a #TypeOnesie
* #TackleType1
* About us
* 30 years of progress * Our people and locations* Meet our team
* Our Board Directors * Scientific Advisory Council * Our celebrity supporters * JDRF around the world * Meeting room hire – 17/18 Angel Gate* Work with us
* Current jobs
* How to apply for a job* Staff stories
* Position statements and reports * Annual reviews and reports * Position statements* Contact us
* For professionals
* Resources for healthcare professionals * The Schools Programme * Let’s Talk About Type 1 Diabetes – School Pack * Schools e-learning moduleDonate
Menu
Back
__
WE FUND TYPE 1 DIABETES RESEARCH TO IMPROVE LIVES AND ONE DAY ERADICATE THE CONDITION FOR GOOD. YOUR SUPPORT MAKES THIS HAPPEN.Donate now
INFORMATION AND SUPPORT CORONAVIRUS - INFORMATION FOR PEOPLE WITH TYPE 1 Get useful links and information about the virus and what people with type 1 diabetes need to know ARE YOU NEWLY DIAGNOSED? Find support and information to help you understand your diagnosis and manage type 1 diabetes WHAT IS TYPE 1 DIABETES? Find out about causes, symptoms, complications and facts and figuresabout type 1
OUR RESEARCH
Discover JDRF's research to cure, treat and prevent type 1 diabetes and its complications.DONATE NOW
Everything we do to drive type 1 diabetes research and support people with this condition is made possible by your generous donations. We receive no government funding.Monthly
Single
£5
£12
£45
£20
£40
£100
Other
Donate now
URGENT APPEAL
COVID-19 is hitting our fundraising income. Less money will mean less research and fewer life-changing breakthroughs. Please donate to help keep our research on track. Donate to our urgent appeal Keep up to date with the latest type 1 diabetes research, news andevents from JDRF
Sign up
LATEST NEWS AND EVENTS REPORT CAPTURES BARRIERS TO MEDICAL TECH CHOICES AND POTENTIAL BETTER HEALTH OUTCOMES FOR PEOPLE WITH TYPE 1 DIABETES A new report captures - for the first time - the barriers, motivations and opportunities voiced by the UK’s type 1 diabetes community on the provision of wearable medical technology choices.Read more
GAME 2 GIVE
We're looking for gamers, streamers and clans to organise an online gaming event for JDRF. Choose your challenge and help raise funds to be part of the next type 1 diabetes breakthrough. Learn more and sign up THERESA MAY, FORMER UK PRIME MINISTER, IS NEW AMBASSADOR FOR TYPE 1 DIABETES RESEARCH CHARITY JDRF Theresa May, who was diagnosed with type 1 diabetes in 2013, will become an Ambassador for JDRF, to champion its global researchprogramme.
Read more
WORLD’S FIRST ARTIFICIAL PANCREAS APP LICENSED FOR PEOPLE WITH TYPE 1 DIABETES IN THE UK Pioneering JDRF researcher Professor Roman Hovorka has launched the first licensed, downloadable artificial pancreas app for people withtype 1 diabetes.
Read more
SCREENING FOR TYPE 1 DIABETES CAN REDUCE THE RISK OF LIFE-THREATENING DIABETIC KETOACIDOSIS (DKA) Widespread screening for type 1 diabetes can dramatically reduce the risk of diabetic ketoacidosis in children, according to the JDRF-funded Fr1da study.Read more
View all news View all events YOU MAY ALSO BE INTERESTED IN VIRTUAL TYPE 1 TEA PARTY Put the kettle on and spend some quali-tea time with your friends and family by holding a Type 1 Tea Party.Learn more
SUPPORT JDRF ON AMAZON Register JDRF as your charity on Amazon Smile and we'll get 0.5% of your spend every time you shop at smile.amazon.co.uk Find more free ways to give TYPE 1 DISCOVERY MAGAZINE OUT NOW! Download issue 85 for research news, updates, interviews with leading type 1 scientists and much moreRead now
Keep up-to-date with our news and events __Newsletter __Instagram __Linkedin __Twitter__Facebook
Help us create a world without type 1 diabetesDonate
JDRF, THE TYPE 1 DIABETES CHARITY We fund research to cure, treat and prevent type 1. We work with government, academia and industry to accelerate research in the UK and within healthcare policy to ensure that the outcomes of research are delivered to people with type 1 in the UK. And we give support and a voice to people with type 1 and their families. Join us in creating a world without type 1 diabetes.JOIN US ONLINE
* __Twitter
* __Facebook
* __LinkedIn
* __Instagram
* __E-newsletter
JDRF
* Contact us
* About us
* Work with us
* Policies and terms of use Copyright © 2018 | Juvenile Diabetes Research Foundation Ltd (JDRF) is a charity registered in England and Wales (No. 295716) and in Scotland (No. SC040123). Registered address: 17/18 Angel Gate, City Road, London EC1V 2PT. Tel: 020 7713 2030. Registered as a company limited by guarantee, in England and Wales (No 2071638). INPUT is a charity registered in England and Wales (No. 1150609) and a registered company limited by guarantee (No. 08289511). By continuing to use the site, you agree to the use of cookies. Moreinformation
Accept
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.Close
KEEP UP TO DATE WITH THE LATEST TYPE 1 DIABETES RESEARCH, NEWS ANDEVENTS FROM JDRF.
To sign up, simply complete your details below and click subscribe.Email*
First name*
Last name*
Your connection to type 1 Please select... Parent of a child with type 1 Adult with type 1 Grandparent of a child with type 1 Family member of someone with type 1 Colleague/friends of someone with type 1 Child with type 1 Healthcare professional School teacher OtherTelephone
I am happy for you to securely store this information about meYes
No
Please let us know which region you are based in so we can keep you informed of events in your area.Scotland
East
London
Midlands
North West
North East
Yorkshire, Humber and AngliaSouth
South West
Wales
Northern Ireland
KEEP IN TOUCH
We'd love to keep you updated about our work to cure, treat and prevent type 1 diabetes, and how we support people with type 1. We'd also like to let you know how you can help by donating, volunteeringor campaigning.
We may stay in touch by post or phone if we have those details from you, but it keeps our costs down if we can use email, meaning that we can invest more money in ground breaking type 1 research. Please let us know if you're happy for us to contact you by email: Yes, I am happy for JDRF to contact me by email No, I don't want to receive emails from JDRF To change how we contact you, or to stop all contact from us, please phone 020 7713 2030 and ask for Supporter Care, or emailinfo@jdrf.org.uk
PRIVACY POLICY
Your privacy is important to us. Please read our privacy policy. OUR SUPPORTER PROMISE We promise that we will treat you and your personal information with the utmost care and respect.Please read our supporter promise.Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0